what are the glp 1 GLP-1 Updates for Employers: Demand, Shortages, and Cost Comparing Ozempic, Wegovy and Other

There are no USA Food and Drug Administrationapproved medications to treat DS or PBH, yet this case report shows promise for tirzepatide as a potential treatment

[DOI] [PubMed] [Google Scholar] 15.Chakhtoura M., Haber R., Ghezzawi M., et al

V., Sussel, L

The Bridge Program is a temporary demonstration project running from July 1, 2026, through December 2027

Short-acting agents undergo renal clearance, so they require once-daily (lixisenatide) or twice-daily (exenatide BD) dosing

This marks the first time Ozempic has been available to consumers at this cash price, expanding access for people who would otherwise be priced out of therapy. With national discussions on drug pricing gaining momentum, there is increasing pressure on pharmaceutical companies to offer direct cash prices to consumers, Iyer noted